Belinostat Interactions
There are 235 drugs known to interact with belinostat, along with 5 disease interactions. Of the total drug interactions, 53 are major, and182 are moderate.
- View belinostat disease interactions (5)
Medications known to interact with belinostat
Note: Showing generic names only.
A
- abametapir topical
- abrocitinib
- adalimumab
- adenovirus vaccine
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- allopurinol
- alpelisib
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- apalutamide
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atazanavir
- azathioprine
B
- baricitinib
- bcg
- bcg vaccine
- bedaquiline
- bifidobacterium infantis
- black cohosh
- brentuximab
- brewer's yeast
- brigatinib
C
- calaspargase pegol
- canakinumab
- candida albicans extract
- cannabidiol
- capivasertib
- capmatinib
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- cholera vaccine
- cholera vaccine, live
- cladribine
- clofarabine
- clozapine
- coccidioidin skin test
D
- daclizumab
- danicopan
- deferiprone
- dengue vaccine
- denosumab
- deucravacitinib
- dimethyl fumarate
- diroximel fumarate
E
- efalizumab
- efavirenz
- efbemalenograstim alfa
- eflapegrastim
- elacestrant
- encorafenib
- enzalutamide
- erdafitinib
- etanercept
- etrasimod
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
I
- idelalisib
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- interferon beta-1a
- interferon beta-1b
- isavuconazonium
- isoniazid
- ivosidenib
J
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lasmiditan
- leflunomide
- lenacapavir
- levoketoconazole
- lomitapide
- lorlatinib
- lyme disease vaccine
M
- mavorixafor
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- methotrexate
- mipomersen
- mixed respiratory vaccine
- monomethyl fumarate
- mumps skin test antigen
- mumps virus vaccine
N
O
P
- pacritinib
- palifermin
- pazopanib
- pegaspargase
- pegfilgrastim
- peginterferon beta-1a
- pemigatinib
- pertussis, acellular
- pexidartinib
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- pralsetinib
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- radium 223 dichloride
- regorafenib
- remdesivir
- rifampin
- rilonacept
- ritlecitinib
- roflumilast
- ropeginterferon alfa-2b
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- rucaparib
S
- saccharomyces boulardii lyo
- samarium sm 153 lexidronam
- sarecycline
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine
- sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent vaccine
- sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 (bivalent booster) vaccine
- sars-cov-2 (covid-19) mrna-1273 bivalent vaccine
- sars-cov-2 (covid-19) mrna-1273 vaccine
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 311)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 312)
- sars-cov-2 (covid-19) mrna(tozinameran12y+) bivalent vaccine
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 (covid-19)mrna-1273(6y+ bivalent booster) vaccine
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- sars-cov-2(covid-19)mrna(tozinameran 5y-11y)bivalent vaccine
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and monkeypox vaccine
- smallpox vaccine
- sodium phenylbutyrate
- sodium phosphate p32
- sorafenib
- staphage lysate (spl)
- streptococcus salivarius
- strontium-89 chloride
T
- tafamidis
- talimogene laherparepvec
- tbo-filgrastim
- teriflunomide
- tetanus toxoid
- thioguanine
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tofacitinib
- topotecan
- trabectedin
- trichophyton skin test
- trofinetide
- tuberculin purified protein derivative
- tucatinib
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
Y
Z
Belinostat disease interactions
There are 5 disease interactions with belinostat which include:
More about belinostat
- belinostat consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: histone deacetylase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.